Meta-Analysis Addressing the Efficacy and Safety of Antiplatelet Agents in Patients With COVID-19.

Am J Cardiol · 2022 · PMC9135494 · PMID 35644695

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

marginally nonsignificantp = 0.08so close (0.05 < p ≤ 0.1)

Concerning the risk for major thrombosis, antiplatelet agents resulted in a marginally nonsignificant decrease in the corresponding risk compared with control (RR = 0.88, 95% CI 0.77 to 1.02, I 2 = 0%, p = 0.08), as shown in Figure 2 .

also in 448 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.